CAMBRIDGE,Mass.,ROTTERDAM,Netherlands and SHANGHAI,Feb. 14,2025-- HarbourBioMed (the "Company"; HKEX: 02142),a global biopharmaceutical company committed to the discovery,development,and co
SEOUL,South Korea,Feb. 14,2025--BUYING SQUARE,a next-generation digital wholesale platform,has announced the global launch of Catalog Shop,a B2B solution designed to streamline wholesale transactions
SHENZHEN,China,Feb. 14,2025--MicroCloud Hologram Inc. (NASDAQ: HOLO),("HOLO" or the "Company"),a technology service provider,they Announced the deep optimization of stacked sparse
SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,
DUBAI,UAE,Feb. 14,2025-- Wearing a "Tech Support"-printed T-shirt,Elon Musk virtually took to the stage on the final day of the World Governments Summit in a live discussion with H.E. Omar S
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.
